Clinical Trials
All Clinical Trials - Page 12 of 74
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT06883851N/ARecruiting
Effectiveness of Pelvic Floor Muscle Rehabilitation Combined With Desmopressin in Children With Primary Monosymptomatic Nocturnal Enuresis
Desmopressin
- NCT06734273EARLY_Phase 1Active Not Recruiting
Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight Loss
Tirzepatide
- NCT06326190Phase 2Recruiting
177Lu-DOTATATE for Recurrent Meningioma
Octreotide
- NCT06582875Phase 2Recruiting
Glucagon-Like Peptide-1 Receptor Agonist in ADPKD
Tirzepatide
- NCT06864026Phase 4Active Not Recruiting
A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)
Tirzepatide
- NCT06859268Phase 3Active Not Recruiting
A Study of Retatrutide (LY3437943) in the Maintenance of Weight Reduction in Individuals With Obesity
Retatrutide
- NCT06774079Phase 4Recruiting
Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients
Tirzepatide
- NCT06772597Phase 2Active Not Recruiting
A Study of Setmelanotide in Patients With Prader-Willi Syndrome
Setmelanotide
- NCT06854614Phase 4Active Not Recruiting
Sequential Therapy Anti-obesitY Medication With Muscle Preservation for Weight Loss and MaintEnance: A PragmAtic Randomized CoNtrolled Trial (STAY-LEAN Trial)
Tirzepatide
- NCT06856928N/ANot Yet Recruiting
Impact of Antiobesity Medications on Appetite and Appetite-related Hormones and Metabolites.
Tirzepatide
- NCT06737042Phase 2Completed
Efficacy and Safety of GZR18 Every 2 Weeks Versus Tirzepatide and Placebo in Obese or Overweight Participants
Tirzepatide
- NCT06814938Phase 4Active Not Recruiting
A Study of a Novel Precision Medicine Approach For Obesity
Semaglutide
- NCT07223242Phase 2/Phase 3Recruiting
Tailored Exercise Training Study Among Adults With HFpEF
Tirzepatide
- NCT06627530Phase 4Active Not Recruiting
COACTION Trial - COmbination Androgen bloCkade in inTermediate to hIgh-risk prOstate caNcer
Gonadorelin
- NCT06824051Phase 1Completed
A Study of Orforglipron (LY3502970) in Adult Participants With Obesity or Overweight
Orforglipron
- NCT06630585Phase 3Recruiting
GIP/GLP-1RA as Adjunctive to Automated Insulin Delivery in Adults With Type 1 Diabetes
Tirzepatide
- NCT06778967Phase 3Active Not Recruiting
A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus
Semaglutide
- NCT06829355Phase 2Recruiting
"Thymalfasin Immunotherapy Study with Triple Regimen in Advanced MSS/pMMR Colorectal Cancer"
Thymosin-Alpha-1
- NCT06780449Phase 3Active Not Recruiting
A Research Study to Look Into the Long-term Effect on Weight Loss of CagriSema in People With Obesity
Semaglutide
- NCT06772532Phase 1Completed
A Study in Healthy People to Compare How 3 Different Formulations of Survodutide Are Taken up in the Body
Survodutide
- NCT06820476Phase 1Completed
A Research Study on How NNC0487-0111, a New Medicine, Works in Chinese Participants After 10 Days of Oral Dosing
Amycretin
- NCT06817356Phase 2Completed
A Study to Evaluate Mazdutide Compared With Placebo in Participants With Alcohol Use Disorder
Mazdutide
- NCT06808802Phase 1Completed
To Investigate the Effect of Retatrutide (LY3437943) on Metoprolol Pharmacokinetics in Healthy Participants
Retatrutide
- NCT06745128Phase 2Completed
Tirzepatide for Obesity and Meth Use Disorder
Tirzepatide
- NCT06558188Phase 4Recruiting
Combined Anabolic Therapy
Teriparatide
- NCT07382180N/ACompleted
Real-World Tirzepatide Therapy in Post-Bariatric Weight Regain and Preoperative Obesity Patients
Tirzepatide
- NCT06788626Phase 3Not Yet Recruiting
Glucagon-like Peptide 1 Receptor Agonist in Acute Large Vessel Occlusion Stroke After Endovascular Treatment
Semaglutide
- NCT06790160N/AActive Not Recruiting
Study of Patients Being Treated With Anti-obesity Medication
Tirzepatide
- NCT06803888Phase 4Active Not Recruiting
Bariatric Surgery vs. Semaglutide vs. Tirzepatide
Tirzepatide
- NCT06797869Phase 2Completed
A Research Study to Investigate the Effects of CagriSema Compared to Placebo in People With Type 2 Diabetes and Painful Diabetic Peripheral Neuropathy
Semaglutide
- NCT06762314Phase 2Completed
Efficacy and Safety of Empagliflozin or Semaglutide in Overweight/Obese Patients With Type 1 Diabetes
Semaglutide
- NCT06793098N/ARecruiting
Functional Proteins in Polycystic Ovary Syndrome
Kisspeptin
- NCT06608433N/ACompleted
Glucagon-like Peptide-1 Receptor Agnoists for the Assessment of Adrenal Function
Semaglutide
- NCT06914141N/ACompleted
Comparative Effectiveness of Tirzepatide Versus Semaglutide in Individuals With Heart Failure With Preserved Ejection Fraction
Tirzepatide
- NCT06914154N/ACompleted
Emulation of the SUMMIT Heart Failure Trial in Healthcare Claims Data
Tirzepatide
- NCT06914102N/ACompleted
Emulation of the STEP-HFpEF DM Heart Failure Trial in Healthcare Claims Data
Semaglutide
- NCT06657209Phase 4Recruiting
Normal-weight Diabetes: Adipocyte-directed Therapy With Pioglitazone or Tirzepatide
Tirzepatide
- NCT06739122Phase 3Recruiting
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)
Dulaglutide
- NCT06771115Phase 2Completed
Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity
Semaglutide
- NCT07190144N/ACompleted
Coronary Flow Reserve Changes After Semaglutide Treatment
Semaglutide
- NCT05726292Phase 2Recruiting
A Study of Enzalutamide Plus the Glucocorticoid Receptor Antagonist Relacorilant Versus Placebo for Patients With High-risk Localized Prostate Cancer
Gonadorelin
- NCT06716424Phase 4Completed
A Study to Investigate Safety and Efficacy of iGlarLixi in Adult Patients With Type 2 Diabetes Mellitus
Lixisenatide
- NCT07740291N/ARecruiting
Tirzepatide Impact Assessment Study
Tirzepatide
- NCT06753864Phase 1Not Yet Recruiting
A Single-center, Open, Randomized, Single-dose, Cross-over Bioequivalence Study to Evaluate the Effects of the Test Formulation Abalparatide Injection and the Reference Formulation Abalparatide Injection (Tymlos®) in Healthy Adult Subjects
Abaloparatide
- NCT07638592N/ACompleted
Tirzepatide-Based Prehabilitation Before Elective Ventral and Incisional Hernia Repair in Patients With Obesity
Tirzepatide
- NCT06918405Phase 3Active Not Recruiting
Efficacy and Safety of Tirzepatide for Weight Management
Tirzepatide
- NCT06980623N/AActive Not Recruiting
Comparative Effectiveness of Tirzepatide vs Semaglutide in Participants With Type 2 Diabetes and Heart Failure With Preserved Ejection Fraction
Tirzepatide
- NCT06734312N/ARecruiting
MAINTAIN (Mucosal AblatIoN Therapy After INcretins)
Tirzepatide
- NCT07281196N/ACompleted
Semaglutide Effects on Sleep Apnea in Patients With Type 2 Diabetes/Obesity and Comorbid Obstructive Sleep Apnea
Semaglutide
- NCT06896981Phase 2/Phase 3Completed
Semaglutide in Women With Polycystic Ovary Syndrome and Obesity
Semaglutide